Evidence reporting that AD patients show increased levels of C9, a final component forming the membrane attack complex, as well as a deficiency of the complement defense protein CD59 (inhibiting the cell lysis), further highlight the lack of regulatory mechanisms of complement-mediated processes in AD. The gene discussed is C9; the disease is Alzheimer disease.